Congratulations to Dr. Matthew Macauley on receiving the 2026 Horace S. Isbell Award
Tag: Alzheimer’s Disease
GlycoNet Investigator receives 2025 Innovation Award
Congratulations to Dr. Matthew Macauley on being recognized at the 2025 University of Alberta Innovation Awards.
GlycoNet Investigator named a Member of the Royal Society of Canada
Congratulations to Dr. Matthew Macauley on being named a Member in the Royal Society of Canada, Canada’s highest academic honour.
Harnessing the power of carbohydrates to improve our health
A better understanding of complex molecules called glycans will bring us closer to disease treatments and innovative solutions to health challenges, say leading researchers.
New study yields significant insight into a major driver of Alzheimer’s Disease
GlycoNet researchers find that CD33 isoforms on the surface of the brain’s microglia can have opposing effects, providing protection or increased susceptibility to Alzheimer’s Disease.